These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22016100)

  • 1. Inhibition of apolipoprotein A-I gene expression by obesity-associated endocannabinoids.
    Haas MJ; Mazza AD; Wong NC; Mooradian AD
    Obesity (Silver Spring); 2012 Apr; 20(4):721-9. PubMed ID: 22016100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of apolipoprotein A-I gene expression by black seed (Nigella sativa) extracts.
    Haas MJ; Onstead-Haas LM; Naem E; Wong NC; Mooradian AD
    Pharm Biol; 2014 Sep; 52(9):1119-27. PubMed ID: 24635344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The endocannabinoids anandamide and 2-arachidonoylglycerol inhibit cholinergic contractility in the human colon.
    Smid SD; Bjorklund CK; Svensson KM; Heigis S; Revesz A
    Eur J Pharmacol; 2007 Dec; 575(1-3):168-76. PubMed ID: 17706636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinic acid induces apolipoprotein A-I gene expression in HepG2 and Caco-2 cell lines.
    Haas MJ; Alamir AR; Sultan S; Chehade JM; Wong NC; Mooradian AD
    Metabolism; 2011 Dec; 60(12):1790-6. PubMed ID: 21664629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of hepatic apolipoprotein A-I gene expression by the isoflavones quercetin and isoquercetrin.
    Haas MJ; Onstead-Haas LM; Szafran-Swietlik A; Kojanian H; Davis T; Armstrong P; Wong NC; Mooradian AD
    Life Sci; 2014 Aug; 110(1):8-14. PubMed ID: 24963805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of apolipoprotein A-I gene expression by vitamin D receptor modulators.
    Wehmeier KR; Mazza A; Hachem S; Ligaray K; Mooradian AD; Wong NC; Haas MJ
    Biochim Biophys Acta; 2008 Feb; 1780(2):264-73. PubMed ID: 18082637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of anandamide on the activation and proliferation of hepatic stellate cells through cannabinoid-2 receptors].
    Liu HY; Yang Q; Duan RX; Zhang YW; Tang WX
    Zhonghua Gan Zang Bing Za Zhi; 2008 Jun; 16(6):430-4. PubMed ID: 18578993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposing actions of endocannabinoids on cholangiocarcinoma growth: recruitment of Fas and Fas ligand to lipid rafts.
    DeMorrow S; Glaser S; Francis H; Venter J; Vaculin B; Vaculin S; Alpini G
    J Biol Chem; 2007 Apr; 282(17):13098-113. PubMed ID: 17329257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Membrane cholesterol mediates the endocannabinoids-anandamide affection on HepG2 cells].
    Wu WJ; Yang Q; Cao QF; Zhang YW; Xia YJ; Hu XW; Tang WX
    Zhonghua Gan Zang Bing Za Zhi; 2010 Mar; 18(3):204-8. PubMed ID: 20380798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of apolipoprotein A-I gene expression by glucagon-like peptide-1 and exendin-4 in hepatocytes but not intestinal cells.
    Chehade JM; Alcalde R; Naem E; Mooradian AD; Wong NC; Haas MJ
    Metabolism; 2013 Feb; 62(2):265-74. PubMed ID: 22901716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.
    Melck D; De Petrocellis L; Orlando P; Bisogno T; Laezza C; Bifulco M; Di Marzo V
    Endocrinology; 2000 Jan; 141(1):118-26. PubMed ID: 10614630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the endocannabinoid system in mouse embryonic stem cells.
    Bari M; Tedesco M; Battista N; Pasquariello N; Pucci M; Gasperi V; Scaldaferri ML; Farini D; De Felici M; Maccarrone M
    Stem Cells Dev; 2011 Jan; 20(1):139-47. PubMed ID: 20446814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid receptor type 1 (CB1R) signaling regulates hepatic gluconeogenesis via induction of endoplasmic reticulum-bound transcription factor cAMP-responsive element-binding protein H (CREBH) in primary hepatocytes.
    Chanda D; Kim DK; Li T; Kim YH; Koo SH; Lee CH; Chiang JY; Choi HS
    J Biol Chem; 2011 Aug; 286(32):27971-9. PubMed ID: 21693703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocannabinoids regulate growth and survival of human eccrine sweat gland-derived epithelial cells.
    Czifra G; Szöllősi AG; Tóth BI; Demaude J; Bouez C; Breton L; Bíró T
    J Invest Dermatol; 2012 Aug; 132(8):1967-76. PubMed ID: 22513781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effects of endocannabinoid anandamide and CB1 receptor antagonist, AM251 in the regulation of thyrotropin secretion.
    da Veiga MA; Fonseca Bloise F; Costa-E-Sousa RH; Souza LL; Almeida NA; Oliveira KJ; Pazos-Moura CC
    J Endocrinol; 2008 Nov; 199(2):235-42. PubMed ID: 18755884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anandamide inhibits the growth of colorectal cancer cells through CB1 and lipid rafts].
    Liao YS; Wu J; Wang P; Zhang H
    Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):256-9. PubMed ID: 21575494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of hepatic apolipoprotein A-I gene expression by histamine.
    Haas MJ; Plazarte M; Chamseddin A; Onstead-Haas L; Wong NCW; Plazarte G; Mooradian AD
    Eur J Pharmacol; 2018 Mar; 823():49-57. PubMed ID: 29378195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of the endocannabinoid system in periodontal healing.
    Kozono S; Matsuyama T; Biwasa KK; Kawahara K; Nakajima Y; Yoshimoto T; Yonamine Y; Kadomatsu H; Tancharoen S; Hashiguchi T; Noguchi K; Maruyama I
    Biochem Biophys Res Commun; 2010 Apr; 394(4):928-33. PubMed ID: 20233580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells.
    Chiba T; Ueno S; Obara Y; Nakahata N
    J Pharm Pharmacol; 2011 May; 63(5):636-47. PubMed ID: 21492165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The endocannabinoid anandamide inhibits kinin B1 receptor sensitization through cannabinoid CB1 receptor stimulation in human umbilical vein.
    Pelorosso FG; Gago JE; Del Rey G; Menéndez SD; Errasti AE; Rothlin RP
    Eur J Pharmacol; 2009 Jan; 602(1):176-9. PubMed ID: 19022239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.